7 Hindi films that depicted Alzheimer’s disease
Hindi films that depicted Alzheimers disease Source link
Alzheimers
Breakthrough Alzheimer’s drugs too pricey to be offered on NHS
Getty Images Two breakthrough Alzheimer’s drugs have been deemed far too expensive, for too little benefit, to be offered on the NHS. The medicines are the first to slow the disease, which may give people extra time living independently. The National Institute for Health and Care Excellence (NICE) concluded they were a poor use of … Read more
Donanemab: NHS will not fund new drug to slow Alzheimer’s
A new drug that slows the pace of Alzheimer’s disease is too expensive for too little benefit to be used on the NHS, the drugs spending watchdog says. Donanemab was hailed as a turning point in the disease last year. But the National Institute of Health and Care Excellence (NICE) said the drug provided only … Read more
Sally Magnusson: Will I be diagnosed with Alzheimer’s like my mother?
Sally Magnusson Sally Magnusson has already written a book about how her family coped with her mother’s dementia There can’t be many people who spend years raging and grieving over the decline of a parent from dementia without wondering if it awaits them too. I’m one. My mother died of this vicious brain condition in … Read more
Lecanemab: Will NHS ever pay for new era of Alzheimer’s drugs?
The first drug shown to slow the destruction of the brain in Alzheimer’s disease will not be available on the NHS after a decision by the medicine’s regulator. The decision on funding lecanemab has caused upset and disappointment from those hoping the drug could help fight a horrible and devastating disease. But the decision is … Read more
Lecanemab: First drug to slow Alzheimer’s too costly for NHS
Getty Images The first drug to slow the progression of early stage Alzheimer’s won’t be available on the NHS in England because health assessment body NICE says the benefits “are too small to justify the costs”. Lecanemab has been licensed by the UK medicines regulator, the MHRA, which means it can be prescribed privately. In … Read more
EU regulator rejects Alzheimer’s drug lecanemab
Getty Images The European Medicines Agency (EMA) has rejected a licence for an Alzheimer’s treatment which slows cognitive decline. The EMA said the benefits of lecanemab did not counterbalance the risk of serious side effects, especially bleeding and swelling in the brain. The medicines regulator in the UK, the MHRA, is still considering whether to … Read more
‘I have a 50:50 chance of developing Alzheimer’s Disease in my 50s’
John Jennings may have inherited a gene from his mother that could trigger early-onset of the condition. Source link
Alzheimer’s: Thousands of volunteers to trial blood tests
The long-term hope is that more people will be able to access new treatments at an earlier stage. Source link
Alzheimer’s drugs might get into the brain faster with new ultrasound tool, study shows – ET HealthWorld
Washington: Scientists have found a way to help Alzheimer’s drugs seep inside the brain faster – by temporarily breaching its protective shield. The novel experiment was a first attempt in just three patients. But in spots in the brain where the new technology took aim, it enhanced removal of Alzheimer’s trademark brain-clogging plaque, researchers reported … Read more